Development and validation of COVID-19 with myocardial injury based on 3 methods

Xiaoqian Yu1, Liling Wang2, Chengzhen Zhang3

  • 1Hospital of Shandong Technology and Business University, Yantai, China.

Medicine
|June 30, 2025
PubMed

Insights

A new prediction model identifies key risk factors for myocardial injury in COVID-19 patients. This model, using age, alcohol history, blood pressure, heart rate, BMI, and cystatin C, aids in early detection and management of cardiac complications in novel coronavirus pneumonia.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Novel coronavirus pneumonia (COVID-19) is a significant global health threat.
  • Myocardial injury affects a substantial proportion of COVID-19 patients (59.6%), yet clinical prediction models are underdeveloped.
  • Effective prediction of cardiac complications is crucial for managing COVID-19 patients.

Purpose of the Study:

  • To develop and validate a clinical prediction model for myocardial injury in COVID-19 patients.
  • To identify key clinical risk factors associated with myocardial injury in this population.
  • To improve early detection and clinical management of cardiac complications in COVID-19.

Main Methods:

  • Retrospective analysis of 1737 COVID-19 patients from December 2022 to December 2023.
  • Utilized logistic regression techniques (1-factor, optimal subset, LASSO) to screen risk factors.
  • Constructed a multifactor logistic regression model and evaluated its performance using ROC curves and calibration analysis.

Main Results:

  • Identified age, alcohol consumption history, diastolic blood pressure, heart rate, body mass index, and cystatin C as significant risk factors for myocardial injury.
  • The prediction model demonstrated good predictive efficacy with an Area Under the Curve (AUC) of 0.78 (0.75-0.81) for the prediction set.
  • Calibration curves indicated high accuracy, with a mean error of 0.02 for both training and validation sets.

Conclusions:

  • A robust clinical prediction model for myocardial injury in COVID-19 patients was successfully developed.
  • The model effectively integrates easily accessible clinical parameters for risk assessment.
  • This tool can aid clinicians in identifying high-risk individuals, facilitating timely intervention and improved patient outcomes.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
26
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
32
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
18
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
352